[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global and China Infectious Disease Rapid Diagnostic Testing Market Size, Status and Forecast 2020-2026

September 2020 | 134 pages | ID: G3E5419E83FFEN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Infectious Disease Rapid Diagnostic Testing Scope and Market Size
Infectious Disease Rapid Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Rapid Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
  • Assays
  • Platforms
Market segment by Application, split into
  • Respiratory Infection
  • Gastro-Intestinal Infection
  • Center Nervous System Infection
  • Hospital Acquired Infection
  • Sexually Transmitted Infections
  • Others
Based on regional and country-level analysis, the Infectious Disease Rapid Diagnostic Testing market has been segmented as follows:
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Mexico
    • Brazil
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Infectious Disease Rapid Diagnostic Testing market are broadly studied on the basis of key factors.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
  • Abbott Laboratories
  • Roche Ltd
  • Danaher Corporation
  • Luminex Corporation
  • BGI Group
  • bioMerieux S.A.
  • DiaSorin S.p.A
  • Hologic, Inc.
  • Mesa Biotech
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • GenMark Diagnostics
  • CTK Biotech
  • Becton Dickinson
  • Cellex Inc.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Assays
  1.2.3 Platforms
1.3 Market by Application
  1.3.1 Global Infectious Disease Rapid Diagnostic Testing Market Share by Application: 2020 VS 2026
  1.3.2 Respiratory Infection
  1.3.3 Gastro-Intestinal Infection
  1.3.4 Center Nervous System Infection
  1.3.5 Hospital Acquired Infection
  1.3.6 Sexually Transmitted Infections
  1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Infectious Disease Rapid Diagnostic Testing Market Perspective (2015-2026)
2.2 Global Infectious Disease Rapid Diagnostic Testing Growth Trends by Regions
  2.2.1 Infectious Disease Rapid Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Infectious Disease Rapid Diagnostic Testing Historic Market Share by Regions (2015-2020)
  2.2.3 Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Market Size
  3.1.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue (2015-2020)
  3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.2 Global Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Rapid Diagnostic Testing Revenue
3.4 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio
  3.4.1 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Rapid Diagnostic Testing Revenue in 2019
3.5 Key Players Infectious Disease Rapid Diagnostic Testing Area Served
3.6 Key Players Infectious Disease Rapid Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Rapid Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2021-2026)

5 INFECTIOUS DISEASE RAPID DIAGNOSTIC TESTING BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Application (2015-2020)
5.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
6.2 North America Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
6.3 North America Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
6.4 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
7.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
8.2 China Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
8.3 China Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
8.4 China Infectious Disease Rapid Diagnostic Testing Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
9.2 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
9.3 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
9.4 Japan Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size (2015-2026)
10.2 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020)
10.3 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020)
10.4 Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11 KEY PLAYERS PROFILES

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Details
  11.1.2 Abbott Laboratories Business Overview
  11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Introduction
  11.1.4 Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020))
  11.1.5 Abbott Laboratories Recent Development
11.2 Roche Ltd
  11.2.1 Roche Ltd Company Details
  11.2.2 Roche Ltd Business Overview
  11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Introduction
  11.2.4 Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.2.5 Roche Ltd Recent Development
11.3 Danaher Corporation
  11.3.1 Danaher Corporation Company Details
  11.3.2 Danaher Corporation Business Overview
  11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Introduction
  11.3.4 Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.3.5 Danaher Corporation Recent Development
11.4 Luminex Corporation
  11.4.1 Luminex Corporation Company Details
  11.4.2 Luminex Corporation Business Overview
  11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Introduction
  11.4.4 Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.4.5 Luminex Corporation Recent Development
11.5 BGI Group
  11.5.1 BGI Group Company Details
  11.5.2 BGI Group Business Overview
  11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Introduction
  11.5.4 BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.5.5 BGI Group Recent Development
11.6 bioMerieux S.A.
  11.6.1 bioMerieux S.A. Company Details
  11.6.2 bioMerieux S.A. Business Overview
  11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Introduction
  11.6.4 bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.6.5 bioMerieux S.A. Recent Development
11.7 DiaSorin S.p.A
  11.7.1 DiaSorin S.p.A Company Details
  11.7.2 DiaSorin S.p.A Business Overview
  11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Introduction
  11.7.4 DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.7.5 DiaSorin S.p.A Recent Development
11.8 Hologic, Inc.
  11.8.1 Hologic, Inc. Company Details
  11.8.2 Hologic, Inc. Business Overview
  11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Introduction
  11.8.4 Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.8.5 Hologic, Inc. Recent Development
11.9 Mesa Biotech
  11.9.1 Mesa Biotech Company Details
  11.9.2 Mesa Biotech Business Overview
  11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Introduction
  11.9.4 Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.9.5 Mesa Biotech Recent Development
11.10 Quidel Corporation
  11.10.1 Quidel Corporation Company Details
  11.10.2 Quidel Corporation Business Overview
  11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Introduction
  11.10.4 Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  11.10.5 Quidel Corporation Recent Development
11.11 Thermo Fisher Scientific Inc.
  10.11.1 Thermo Fisher Scientific Inc. Company Details
  10.11.2 Thermo Fisher Scientific Inc. Business Overview
  10.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Introduction
  10.11.4 Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  10.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 GenMark Diagnostics
  10.12.1 GenMark Diagnostics Company Details
  10.12.2 GenMark Diagnostics Business Overview
  10.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Introduction
  10.12.4 GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  10.12.5 GenMark Diagnostics Recent Development
11.13 CTK Biotech
  10.13.1 CTK Biotech Company Details
  10.13.2 CTK Biotech Business Overview
  10.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Introduction
  10.13.4 CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  10.13.5 CTK Biotech Recent Development
11.14 Becton Dickinson
  10.14.1 Becton Dickinson Company Details
  10.14.2 Becton Dickinson Business Overview
  10.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Introduction
  10.14.4 Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  10.14.5 Becton Dickinson Recent Development
11.15 Cellex Inc.
  10.15.1 Cellex Inc. Company Details
  10.15.2 Cellex Inc. Business Overview
  10.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Introduction
  10.15.4 Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
  10.15.5 Cellex Inc. Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES

Table 1. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Assays
Table 4. Key Players of Platforms
Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Infectious Disease Rapid Diagnostic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Infectious Disease Rapid Diagnostic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Market Share by Regions (2015-2020)
Table 9. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Infectious Disease Rapid Diagnostic Testing Market Share by Regions (2021-2026)
Table 11. Infectious Disease Rapid Diagnostic Testing Market Market Trends
Table 12. Infectious Disease Rapid Diagnostic Testing Market Drivers
Table 13. Infectious Disease Rapid Diagnostic Testing Market Challenges
Table 14. Infectious Disease Rapid Diagnostic Testing Market Restraints
Table 15. Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players (2015-2020)
Table 17. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2019)
Table 18. Global Infectious Disease Rapid Diagnostic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Rapid Diagnostic Testing Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Infectious Disease Rapid Diagnostic Testing Market Size Share by Type (2015-2020)
Table 24. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type (2021-2026)
Table 25. Global Infectious Disease Rapid Diagnostic Testing Market Size Share by Application (2015-2020)
Table 26. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Infectious Disease Rapid Diagnostic Testing Market Size Share by Application (2021-2026)
Table 28. North America Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Infectious Disease Rapid Diagnostic Testing Market Share by Type (2015-2020)
Table 30. North America Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Infectious Disease Rapid Diagnostic Testing Market Share by Application (2015-2020)
Table 32. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Infectious Disease Rapid Diagnostic Testing Market Share by Country (2015-2020)
Table 34. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Infectious Disease Rapid Diagnostic Testing Market Share by Type (2015-2020)
Table 36. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Infectious Disease Rapid Diagnostic Testing Market Share by Application (2015-2020)
Table 38. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Infectious Disease Rapid Diagnostic Testing Market Share by Country (2015-2020)
Table 40. China Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 41. China Infectious Disease Rapid Diagnostic Testing Market Share by Type (2015-2020)
Table 42. China Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 43. China Infectious Disease Rapid Diagnostic Testing Market Share by Application (2015-2020)
Table 44. China Infectious Disease Rapid Diagnostic Testing Market Size by Region (US$ Million) (2015-2020)
Table 45. China Infectious Disease Rapid Diagnostic Testing Market Share by Region (2015-2020)
Table 46. Japan Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Infectious Disease Rapid Diagnostic Testing Market Share by Type (2015-2020)
Table 48. Japan Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Infectious Disease Rapid Diagnostic Testing Market Share by Application (2015-2020)
Table 50. Japan Infectious Disease Rapid Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Infectious Disease Rapid Diagnostic Testing Market Share by Country (2015-2020)
Table 52. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Share by Type (2015-2020)
Table 54. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Share by Application (2015-2020)
Table 56. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Share by Country (2015-2020)
Table 58. Abbott Laboratories Company Details
Table 59. Abbott Laboratories Business Overview
Table 60. Abbott Laboratories Product
Table 61. Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 62. Abbott Laboratories Recent Development
Table 63. Roche Ltd Company Details
Table 64. Roche Ltd Business Overview
Table 65. Roche Ltd Product
Table 66. Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 67. Roche Ltd Recent Development
Table 68. Danaher Corporation Company Details
Table 69. Danaher Corporation Business Overview
Table 70. Danaher Corporation Product
Table 71. Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 72. Danaher Corporation Recent Development
Table 73. Luminex Corporation Company Details
Table 74. Luminex Corporation Business Overview
Table 75. Luminex Corporation Product
Table 76. Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 77. Luminex Corporation Recent Development
Table 78. BGI Group Company Details
Table 79. BGI Group Business Overview
Table 80. BGI Group Product
Table 81. BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 82. BGI Group Recent Development
Table 83. bioMerieux S.A. Company Details
Table 84. bioMerieux S.A. Business Overview
Table 85. bioMerieux S.A. Product
Table 86. bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 87. bioMerieux S.A. Recent Development
Table 88. DiaSorin S.p.A Company Details
Table 89. DiaSorin S.p.A Business Overview
Table 90. DiaSorin S.p.A Product
Table 91. DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 92. DiaSorin S.p.A Recent Development
Table 93. Hologic, Inc. Business Overview
Table 94. Hologic, Inc. Product
Table 95. Hologic, Inc. Company Details
Table 96. Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 97. Hologic, Inc. Recent Development
Table 98. Mesa Biotech Company Details
Table 99. Mesa Biotech Business Overview
Table 100. Mesa Biotech Product
Table 101. Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 102. Mesa Biotech Recent Development
Table 103. Quidel Corporation Company Details
Table 104. Quidel Corporation Business Overview
Table 105. Quidel Corporation Product
Table 106. Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 107. Quidel Corporation Recent Development
Table 108. Thermo Fisher Scientific Inc. Company Details
Table 109. Thermo Fisher Scientific Inc. Business Overview
Table 110. Thermo Fisher Scientific Inc. Product
Table 111. Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 112. Thermo Fisher Scientific Inc. Recent Development
Table 113. GenMark Diagnostics Company Details
Table 114. GenMark Diagnostics Business Overview
Table 115. GenMark Diagnostics Product
Table 116. GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 117. GenMark Diagnostics Recent Development
Table 118. CTK Biotech Company Details
Table 119. CTK Biotech Business Overview
Table 120. CTK Biotech Product
Table 121. CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 122. CTK Biotech Recent Development
Table 123. Becton Dickinson Company Details
Table 124. Becton Dickinson Business Overview
Table 125. Becton Dickinson Product
Table 126. Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 127. Becton Dickinson Recent Development
Table 128. Cellex Inc. Company Details
Table 129. Cellex Inc. Business Overview
Table 130. Cellex Inc. Product
Table 131. Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2015-2020) (US$ Million)
Table 132. Cellex Inc. Recent Development
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Infectious Disease Rapid Diagnostic Testing Market Share by Type: 2020 VS 2026
Figure 2. Assays Features
Figure 3. Platforms Features
Figure 4. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application: 2020 VS 2026
Figure 5. Respiratory Infection Case Studies
Figure 6. Gastro-Intestinal Infection Case Studies
Figure 7. Center Nervous System Infection Case Studies
Figure 8. Hospital Acquired Infection Case Studies
Figure 9. Sexually Transmitted Infections Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease Rapid Diagnostic Testing Report Years Considered
Figure 12. Global Infectious Disease Rapid Diagnostic Testing Market Size (US$ Million), YoY Growth 2015-2026
Figure 13. Global Infectious Disease Rapid Diagnostic Testing Market Share by Regions: 2020 VS 2026
Figure 14. Global Infectious Disease Rapid Diagnostic Testing Market Share by Regions (2021-2026)
Figure 15. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players in 2019
Figure 16. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2019
Figure 18. North America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. United States Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Canada Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Europe Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Germany Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. France Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. U.K. Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Italy Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Russia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Nordic Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Rest of Europe Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. China Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Japan Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. South Korea Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. India Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Australia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Latin America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Mexico Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Brazil Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Turkey Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. UAE Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Abbott Laboratories Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 46. Roche Ltd Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 47. Danaher Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 48. Luminex Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 49. BGI Group Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 50. bioMerieux S.A. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 51. DiaSorin S.p.A Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 52. Hologic, Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 53. Mesa Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 54. Quidel Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 55. Thermo Fisher Scientific Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 56. GenMark Diagnostics Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 57. CTK Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 58. Becton Dickinson Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 59. Cellex Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed


More Publications